GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Diagnostics & Research » Apures Co Ltd (XKRX:149300) » Definitions » Additional Paid-In Capital

Apures Co (XKRX:149300) Additional Paid-In Capital : ₩33,795.9 Mil(As of Dec. 2023)


View and export this data going back to 2019. Start your Free Trial

What is Apures Co Additional Paid-In Capital?


Apures Co's quarterly additional paid-in capital increased from Dec. 2021 (₩30,709.8 Mil) to Dec. 2022 (₩31,887.3 Mil) and increased from Dec. 2022 (₩31,887.3 Mil) to Dec. 2023 (₩33,795.9 Mil).

Apures Co's annual additional paid-in capital increased from Dec. 2021 (₩30,709.8 Mil) to Dec. 2022 (₩31,887.3 Mil) and increased from Dec. 2022 (₩31,887.3 Mil) to Dec. 2023 (₩33,795.9 Mil).

Apures Co Additional Paid-In Capital Historical Data

The historical data trend for Apures Co's Additional Paid-In Capital can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Apures Co Additional Paid-In Capital Chart

Apures Co Annual Data
Trend Dec14 Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23
Additional Paid-In Capital
Get a 7-Day Free Trial Premium Member Only Premium Member Only 12,570.57 12,570.57 30,709.78 31,887.28 33,795.93

Apures Co Semi-Annual Data
Dec14 Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23
Additional Paid-In Capital Get a 7-Day Free Trial Premium Member Only Premium Member Only 12,570.57 12,570.57 30,709.78 31,887.28 33,795.93

Apures Co Additional Paid-In Capital Calculation

Capital that a company raises in a financing round in excess of the capital's par value. The account represents the excess paid by an investor over the par-value price of a stock issue. Additional paid-in-capital can arise from issuing either preferred or common stock.

Additional Paid-In Capital is calculated as

Additional Paid-In Capital=(Issue Price-Par Value)* Shares Outstanding (Diluted Average)

Apures Co Additional Paid-In Capital Related Terms

Thank you for viewing the detailed overview of Apures Co's Additional Paid-In Capital provided by GuruFocus.com. Please click on the following links to see related term pages.

Apures Co (XKRX:149300) Business Description

Industry
GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Diagnostics & Research » Apures Co Ltd (XKRX:149300) » Definitions » Additional Paid-In Capital
Comparable Companies
XKRX:246250 XKRX:086460 XKRX:303360 XKRX:236340 XKRX:109820 XKRX:229000 XKRX:347740 XKRX:031860 XKRX:221800 XKRX:245620 TMO DHR SHSE:603259 IDXX IQV A XSWX:LONN MTD ICLR ILMN
Traded in Other Exchanges
N/A
Address
44, Hansan-gil, Cheongbuk-eup, Gyeonggi-do, Pyeongtaek-si, KOR, 17792
Website
http://www.apures.com
Apures Co Ltd is a South Korea based company engaged in the development of transgenic animals to support bio heterogeneous long-term commercialization and new drug efficacy research. It has focused its research capabilities on developing transgenic mini pigs based on gene editing technology and somatic cell nuclear transfer technology.

Apures Co (XKRX:149300) Headlines

No Headlines